Skip to content

Minal Borsada, MD

NPI 1457485500ActiveIndividual· Internal Medicine· Anaheim, CA

Internal Medicine (MD) in Anaheim, California, licensed in CA, with an NPI issued in March 2007. Part D covered 347 prescriptions written in 2024, 88% of them generic. Novo Nordisk Inc was the largest of 3 companies reporting payments in 2025, $341.01 in all, mostly food and beverage.

Overview

NPI1457485500
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 14, 2007
Last updated in NPPESFeb 25, 2025
Certified by providerFeb 25, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XA66056CA
Specialist174400000XA066056CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)347 · 715 30-day fills
Patients54
Total drug cost$23,298
Generic share88% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$341.01 · 5 payments from 3 companies
  • 2024$559.90 · 8 payments from 5 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$257.563
Exact Sciences Corporation$57.861
Gilead Sciences, Inc.$25.591

What the 2025 payments were for

  • Food and Beverage$341.01 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Anaheim

All 235 internal medicine physicians in Anaheim · All internal medicine physicians in California